Completed Global Pharma/Bio Projects Amount to $30 Billion in 2018, an Industrial Info Market Brief
Completed Global Pharma/Bio Projects Amount to $30 Billion in 2018, an Industrial Info Market Brief
Attachment: pharma
By the time 2018 comes to a close, construction is scheduled to be complete on nearly 2,400 pharma-bio capex/MRO projects across the globe, according to Industrial Info's Pharmaceutical-Biotech Market Business Intelligence Platform. The projects represent a total investment value (TIV) of almost $30 billion. The project types run the gamut from simple equipment upgrades to $1 billion grassroot advanced drug manufacturing plants.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects